SCHEMBL19721957

SCHEMBL19721957

C=C(CCCO)C(=O)OCCOc1ccc(-c2ccc(C3CCC(C4CCC(CCCCC)CC4)CC3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 1/20 0.40
▸ RARB P10826 5/20 0.36
▸ ITGB3 P05106 3/20 0.35
▸ ITGA2B P08514 3/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ P2RY14 Q15391 1/20 0.35
▸ S1PR3 Q99500 1/20 0.35
▸ HRH2 P25021 1/20 0.34
▸ HRH1 P35367 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ FFAR4 Q5NUL3 2/20 0.33
▸ RARA P10276 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19722112 0.93 RAB9A (0.42) RAB9ARARBITGB3ITGA2BCYP2C9
SCHEMBL19722045 0.92 RAB9A (0.41) RAB9ARARBITGB3ITGA2BCYP2C9
SCHEMBL19722125 0.89 RAB9A (0.43) RAB9ARARBITGB3ITGA2BCYP2C9
SCHEMBL19722549 0.89 RAB9A (0.43) RAB9AITGB3ITGA2BCYP2C9S1PR3
SCHEMBL19721996 0.86 RAB9A (0.46) RAB9AITGB3ITGA2BCYP2C9S1PR3
SCHEMBL19722609 0.86 RAB9A (0.46) RAB9AITGB3ITGA2BCYP2C9S1PR3
SCHEMBL19722154 0.85 RAB9A (0.45) RAB9AITGB3ITGA2BCYP2C9S1PR3
SCHEMBL19722556 0.84 MMP2 (0.36) RAB9ARARBITGB3ITGA2BCYP2C9
SCHEMBL19722069 0.83 RAB9A (0.43) RAB9AITGB3ITGA2BCYP2C9S1PR3
SCHEMBL20313544 0.83 RAB9A (0.43) RAB9AITGB3ITGA2BCYP2C9S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214615-A1 LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT JNC CORPORATION (JP) 2021-07-15 — — US disclosed
EP-3257839-B1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORP (JP) 2019-09-04 — — EP disclosed
US-10392339-B2 Polymerizable polar compound, liquid crystal composition, and liquid crystal display element JNC CORPORATION (JP) 2019-08-27 — — US disclosed
US-20170369418-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC CORPORATION (JP) 2017-12-28 — — US disclosed
EP-3257839-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC Corporation (JP) 2017-12-20 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10392339-B2 Polymerizable polar compound, liquid crystal composition, and liquid crystal display element SP1, HVCN1, CXCR1 RAB9A 3751/4885RARB 2607/4885ITGB3 2716/4885
US-20170369418-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT SP1, SPIN1, SAV1 RAB9A 3798/4885RARB 1568/4885ITGB3 3454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback